Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2008-09-15
2010-10-12
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S185100, C424S192100, C424S234100, C424S247100
Reexamination Certificate
active
07811584
ABSTRACT:
The present invention is directed to multivalent Clostridial toxin comprising more than one binding domain directed to a cell surface molecule of a target cell. Such modified toxins are useful as therapeutic compositions to prevent exocytosis and secretion by the target cell. Conditions in which such compositions man be useful include, without limitation, disorders of the sensory or motor nervous system, acute or chronic pain, cancer, pancreatitis, hyperhydrosis, glandular disorders, viral infections, cystic fibrosis and the like. The invention is also directed to methods of using and administering such a composition, and methods of treating a given condition using such a composition.
REFERENCES:
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5670484 (1997-09-01), Binder
patent: 5714468 (1998-02-01), Binder
patent: 5989545 (1999-11-01), Foster et al.
patent: 6063768 (2000-05-01), First
patent: 6113915 (2000-09-01), Aoki et al.
patent: 6139845 (2000-10-01), Donovan
patent: 6143306 (2000-11-01), Donovan
patent: 6203794 (2001-03-01), Dolly et al.
patent: 6261572 (2001-07-01), Donovan
patent: 6265379 (2001-07-01), Donovan
patent: 6299893 (2001-10-01), Schwartz et al.
patent: 6306403 (2001-10-01), Donovan
patent: 6319505 (2001-11-01), Aoki et al.
patent: 6337075 (2002-01-01), Donovan
patent: 6358917 (2002-03-01), Carruthers et al.
patent: 6358926 (2002-03-01), Donovan
patent: 6368605 (2002-04-01), Donovan
patent: 6395513 (2002-05-01), Foster et al.
patent: 6416765 (2002-07-01), Donovan
patent: 6423319 (2002-07-01), Brooks et al.
patent: 6458365 (2002-10-01), Aoki
patent: 6464986 (2002-10-01), Aoki et al.
patent: 6500436 (2002-12-01), Donovan
patent: 6565870 (2003-05-01), Donovan
patent: 6620415 (2003-09-01), Donovan
patent: 6623742 (2003-09-01), Voet
patent: 6632440 (2003-10-01), Quinn et al.
patent: 6641820 (2003-11-01), Donovan
patent: 6683049 (2004-01-01), Aoki et al.
patent: 6740321 (2004-05-01), Donovan
patent: 6767544 (2004-07-01), Brooks et al.
patent: 6776990 (2004-08-01), Sachs et al.
patent: 6776992 (2004-08-01), Aoki et al.
patent: 6827931 (2004-12-01), Donovan
patent: 6831059 (2004-12-01), Donovan
patent: 6838434 (2005-01-01), Voet
patent: 6843998 (2005-01-01), Steward et al.
patent: 6869610 (2005-03-01), Aoki et al.
patent: 6872397 (2005-03-01), Aoki et al.
patent: 6989545 (2006-01-01), Rathmell et al.
patent: 7052702 (2006-05-01), Duggan et al.
patent: 7056729 (2006-06-01), Donovan
patent: 7132259 (2006-11-01), Dolly et al.
patent: 7138127 (2006-11-01), Donovan
patent: 7192596 (2007-03-01), Shone et al.
patent: 7244436 (2007-07-01), Donovan
patent: 7244437 (2007-07-01), Donovan
patent: 7262291 (2007-08-01), Donovan
patent: 7276473 (2007-10-01), Sachs et al.
patent: 7413742 (2008-08-01), Donovan
patent: 7419676 (2008-09-01), Dolly et al.
patent: 7422877 (2008-09-01), Dolly et al.
patent: 7425338 (2008-09-01), Donovan
patent: 7514088 (2009-04-01), Steward et al.
patent: 2002/0010138 (2002-01-01), Aoki et al.
patent: 2002/0169942 (2002-11-01), Sugimoto
patent: 2003/0166238 (2003-09-01), Shone et al.
patent: 2003/0180289 (2003-09-01), Foster et al.
patent: 2003/0211121 (2003-11-01), Donovan
patent: 2004/0013692 (2004-01-01), Aoki et al.
patent: 2004/0037852 (2004-02-01), Aoki et al.
patent: 2004/0062776 (2004-04-01), Voet
patent: 2004/0071736 (2004-04-01), Quinn et al.
patent: 2004/0086531 (2004-05-01), Barron
patent: 2004/0115139 (2004-06-01), Katz et al.
patent: 2004/0126396 (2004-07-01), Aoki et al.
patent: 2004/0126397 (2004-07-01), Aoki et al.
patent: 2004/0151740 (2004-08-01), Aoki et al.
patent: 2004/0175399 (2004-09-01), Schiffman
patent: 2004/0176299 (2004-09-01), Sachs et al.
patent: 2004/0180061 (2004-09-01), Donovan
patent: 2004/0234532 (2004-11-01), First
patent: 2004/0253274 (2004-12-01), Voet
patent: 2005/0031648 (2005-02-01), Brin et al.
patent: 2006/0024331 (2006-02-01), Fernandez-Salas
patent: 2006/0211619 (2006-09-01), Steward et al.
patent: 2008/0032930 (2008-02-01), Steward et al.
patent: 2008/0032931 (2008-02-01), Steward et al.
patent: 2008/0081355 (2008-04-01), Dolly et al.
patent: 2008/0095872 (2008-04-01), Donovan
patent: 2008/0096248 (2008-04-01), Steward et al.
patent: 2008/0161226 (2008-07-01), Steward et al.
patent: 2008/0161543 (2008-07-01), Steward et al.
patent: 2008/0187960 (2008-08-01), Foster et al.
patent: 2008/0213311 (2008-09-01), Donovan
patent: 2008/0213830 (2008-09-01), Steward et al.
patent: 2008/0221012 (2008-09-01), Steward et al.
patent: 2008/0241881 (2008-10-01), Steward et al.
patent: 2008/0311622 (2008-12-01), Dolly et al.
patent: 2008/0317782 (2008-12-01), Donovan
patent: 2008/0317783 (2008-12-01), Donovan
patent: 2009/0004224 (2009-01-01), Steward et al.
patent: 2009/0004225 (2009-01-01), Fernandez-Salas et al.
patent: 2009/0005313 (2009-01-01), Steward et al.
patent: 2009/0010967 (2009-01-01), Donovan
patent: 2009/0017071 (2009-01-01), Donovan
patent: 2009/0018081 (2009-01-01), Steward et al.
patent: 2009/0023901 (2009-01-01), Steward et al.
patent: 2009/0028908 (2009-01-01), Donovan
patent: 2009/0030182 (2009-01-01), Dolly et al.
patent: 2009/0030188 (2009-01-01), Dolly et al.
patent: 2009/0035822 (2009-02-01), Foster et al.
patent: 2009/0042270 (2009-02-01), Dolly et al.
patent: 2009/0042799 (2009-02-01), Donovan
patent: 2009/0069238 (2009-03-01), Steward et al.
patent: 2009/0081730 (2009-03-01), Dolly et al.
patent: 2009/0087458 (2009-04-01), Dolly et al.
patent: 2009/0104234 (2009-04-01), Francis et al.
patent: 2009/0117157 (2009-05-01), Brin et al.
patent: WO 94/21300 (1994-09-01), None
patent: WO 95/32738 (1995-12-01), None
patent: WO 96/33273 (1996-10-01), None
patent: WO 98/07864 (1998-02-01), None
patent: WO 99/17806 (1999-04-01), None
patent: WO 99/29721 (1999-06-01), None
patent: WO 99/55359 (1999-11-01), None
patent: WO 01/14570 (2001-03-01), None
patent: WO 02/40506 (2002-05-01), None
patent: WO 02/44199 (2002-06-01), None
patent: WO 2004/024909 (2004-03-01), None
patent: WO 2005/023309 (2005-03-01), None
patent: WO 2005/035730 (2005-04-01), None
patent: WO 2005/068494 (2005-07-01), None
patent: WO 2005/077416 (2005-08-01), None
patent: WO 2006/011966 (2006-02-01), None
patent: WO 2006/017749 (2006-02-01), None
patent: WO 2006/026780 (2006-03-01), None
patent: WO 2006/027207 (2006-03-01), None
patent: WO 2006/059093 (2006-06-01), None
patent: WO 2006/059105 (2006-06-01), None
patent: WO2006/059113 (2006-06-01), None
patent: WO2006/099590 (2006-09-01), None
patent: WO 2006/101809 (2006-09-01), None
Johnson et al., “Clostridial botulinum and its Neurotoxins: A Metabolic and Cellular Perspective”,39 Toxicon, 1703-1722 (2001).
Raffestin et al., “Organization and Regulation of the Neurotoxin Genes in Clostridium botulinum and Clostridium tetani”,10 Anaerobe, 93-100 (2004).
Inoue et al., “Structural Analysis by X-Ray Crystallography and Calorimetry of Haemagglutinin Component (HA1) of the Progenitor Toxin from Clostridium botulinum”,149 Microbiol., 3361-3370 (2003).
Arndt et al., “The Structure of the Neurotoxin-Associated Protein HA33/A from Clostridial botulinum Suggests a Reoccurring β-trefoil Fold in the Progenitor Toxin Complex”,346 J. Mol. Biol., 1083-1093 (2005).
Zhou et al., “Haemagglutinin-33 of Type Q Botulinum Neurotoxin Complex Binds with Synaptotagmin II”,272 Febs Lett., 2717-2726 (2005).
Bonifacino et al.,J. Cell Biol. 145: 923 (1999).
Drapkin et al.,J. Clin. Invest. 105: 589-596 (2000).
Duman & Forte,Am. J. Physiol. Cell Physiol. 285: C237-C249 (2003).
Morris M.C., et al.,Nature Biotechnology, 19:1173-1176 (2001).
Embury et al.,Diabetes, 50:1706-1713 (2001).
Schwartz, J.J. et al., “Peptide-mediated cellular delivery”,Curr. Opin. Mol. Therapeutics, 2:162-7 (2000).
Prochiantz, A., “Messenger proteins:homeoproteins, TAT and others”,Curr. Opin. Cell. Biol., 12:400-6 (2000).
Ho, A. et al., “Synthetic PTDs: enhanced transduction potential in vitro and in vivo”,Cancer Res., 61, 474-7 (2001).
Wender, P.A. et al., “The Design, Synthesis, And Evaluation of Molecules That En
Aoki Kei Roger
Fernandez-Salas Ester
Francis Joseph
Gilmore Marcella A.
Li Shengwen
Abel Kenton
Allergan Inc.
Condino Debra
German Joel
Swartz Rodney P.
LandOfFree
Multivalent clostridial toxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multivalent clostridial toxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent clostridial toxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4184353